Innova Captab Q4FY26 Results: Net profit rises 41% YoY to ₹403.5 crore

scanx
Reviewed by
Anirudha BScanX News Team
Key Highlights
  • Innova Captab revised Q4FY26 and FY26 results due to deferred tax accounting errors
  • Consolidated net profit rose 41% YoY to ₹403.5 crore for Q4FY26
  • Full-year revenue grew to ₹16,300.2 million, up from ₹12,436.8 million in FY25
  • Board approved ₹45 crore brownfield expansion at Baddi facility
  • Auditor B S R & Co. LLP issued unmodified opinion on revised results
powered bylight_fuzz_icon
48901716

*this image is generated using AI for illustrative purposes only.

Innova Captab revised its consolidated financial results for the quarter and fiscal year ended March 31, 2026, following the identification of inadvertent accounting errors. The Board of Directors approved the restated figures on August 21, 2026, alongside a plan to expand its manufacturing capacity in Himachal Pradesh.

The revisions primarily involved the retrospective correction of deferred tax liabilities related to a historical business combination and the recognition of a deferred tax asset under Section 80JJAA of the Income Tax Act. Additionally, the company reclassified ₹185.08 million in supplier finance arrangements from trade payables to other financial liabilities.

Revised Financial Performance

For the quarter ended March 31, 2026, consolidated revenue from operations stood at ₹4,478.02 million, up from ₹3,147.41 million in the corresponding quarter of the previous year. Consolidated net profit for the period rose to ₹403.49 million, compared to ₹285.66 million in Q4FY25.

Metric Q4FY26 (Revised) Q4FY25 (Restated) Change
Revenue from operations ₹4,478.02 million ₹3,147.41 million +42.3%
Net Profit ₹403.49 million ₹285.66 million +41.2%
Earnings Per Share ₹7.05 ₹4.99 +41.3%

For the full fiscal year ended March 31, 2026, consolidated revenue reached ₹16,300.18 million, an increase from ₹12,436.76 million in FY25. Net profit for the year was reported at ₹1,431.83 million, up from ₹1,272.51 million in the prior year.

What the Numbers Show

The revision of the deferred tax liability related to the acquisition of Sharon Bio-Medicine Limited had a material impact on equity. As of April 1, 2024, total assets were reduced by ₹105.37 million due to this correction. Similarly, for the year ended March 31, 2025, deferred tax expense increased by ₹10.07 million, reducing the previously reported profit for the year by the same amount. The recognition of the Section 80JJAA tax asset in FY26 reduced the total tax expense by ₹22.66 million compared to the originally approved figures, thereby boosting the reported net profit.

Capacity Expansion Plan

The Board approved a brownfield expansion of the manufacturing facility located at Baddi, Himachal Pradesh. The project involves adding two Oral Solid Dosage production lines to the existing infrastructure, which currently operates at approximately 85% to 90% capacity utilization.

  • Investment: Approximately ₹45 crore
  • Financing: Bank credit facilities and internal accruals
  • Timeline: Expected completion within 18 to 22 months

The expansion aims to improve operational efficiency and support long-term growth strategies. Statutory auditors B S R & Co. LLP issued an unmodified opinion on the revised standalone and consolidated financial results.

Historical Stock Returns for Innova Captab

1 Day5 Days1 Month6 Months1 Year5 Years
+0.40%+3.91%+11.84%+62.58%+20.91%+101.05%

How will the recognition of the Section 80JJAA tax asset impact Innova Captab's future effective tax rates and cash flow projections?

What specific market opportunities or client contracts is the new Himachal Pradesh capacity expansion intended to capture upon completion?

Could the recent accounting restatements affect investor confidence or trigger any regulatory scrutiny regarding internal financial controls?

Innova Captab Q1FY27 net profit rises 42% to ₹441.26 mn on revenue growth

scanx
Reviewed by
Jubin VScanX News Team
Key Highlights

Innova Captab Limited delivered strong Q1FY27 results with consolidated net profit rising 42.3% to ₹441.26 million and revenue growing 33.9% to ₹4,708.52 million. Standalone metrics showed even sharper improvement, with net profit surging 58.0% to ₹320.60 million. The company is addressing inadvertent errors in its FY26 financial statements ahead of the AGM, though these have no material impact on current quarter performance.

powered bylight_fuzz_icon
48015504

*this image is generated using AI for illustrative purposes only.

Innova Captab Limited reported a consolidated net profit of ₹441.26 million for the quarter ended June 30, 2026, marking a 42.3% increase from ₹310.15 million in the corresponding period last year. Revenue from operations rose 33.9% to ₹4,708.52 million from ₹3,515.42 million, reflecting robust top-line growth driven by higher sales volume. The Board of Directors approved the unaudited financial results on August 11, 2026, alongside an amendment to the Policy for Determination of Materiality of Events or Information to align with recent Securities and Exchange Board of India (SEBI) regulations.

The Board also disclosed that certain inadvertent errors were identified in the standalone and consolidated financial statements for the financial year ended March 31, 2026, subsequent to their approval on May 7, 2026. Management stated that the company is in the process of making necessary corrections before the ensuing annual general meeting. These revisions do not have any material impact on the Q1FY27 results or the comparative information presented therein. The matter will be placed before the Board at its next meeting for final approval.

Consolidated Financial Performance

Consolidated total income stood at ₹4,728.59 million, compared to ₹3,560.25 million in Q1FY26. Total expenses increased to ₹4,138.74 million from ₹3,133.48 million, primarily due to higher cost of materials consumed, which rose to ₹3,079.81 million from ₹2,294.44 million. Profit before tax grew 38.2% to ₹589.85 million. Tax expense for the quarter was ₹148.59 million, comprising ₹110.03 million in current tax and ₹38.56 million in deferred tax.

Particulars Q1FY27 (₹ mn) Q1FY26 (₹ mn) YoY Change
Revenue from Operations 4,708.52 3,515.42 33.9%
Total Income 4,728.59 3,560.25 32.8%
Total Expenses 4,138.74 3,133.48 32.1%
Profit Before Tax 589.85 426.77 38.2%
Net Profit After Tax 441.26 310.15 42.3%
EPS (₹) 7.71 5.42 42.3%

Standalone Results and Analytical Observation

On a standalone basis, Innova Captab reported a net profit of ₹320.60 million, up 58.0% from ₹202.95 million in Q1FY26. Standalone revenue from operations grew 39.6% to ₹4,004.76 million. Basic earnings per share stood at ₹5.60, compared to ₹3.55 in the previous year’s quarter.

What the Numbers Show

The divergence between standalone and consolidated performance highlights the contribution of subsidiaries. While standalone revenue grew nearly 40%, consolidated revenue growth was slightly lower at 33.9%, suggesting varying growth rates across group entities. Notably, consolidated other income declined to ₹20.07 million from ₹44.83 million in Q1FY26, indicating a reduced reliance on non-operating income streams compared to the prior year. The statutory auditors, B S R & Co. LLP, issued an unmodified review conclusion on both standalone and consolidated results.

Historical Stock Returns for Innova Captab

1 Day5 Days1 Month6 Months1 Year5 Years
+0.40%+3.91%+11.84%+62.58%+20.91%+101.05%

How might the identified inadvertent errors in FY26 financials impact investor confidence and the company's regulatory standing once corrected?

Will the rising cost of materials consumed continue to pressure margins, or does management have hedging strategies to offset input cost inflation?

What specific operational factors are driving the divergence between the stronger standalone growth and the slightly lower consolidated revenue growth?

More News on Innova Captab

1 Year Returns:+20.91%